Vasoactive systems in L-NAME hypertension: The role of inducible nitric oxide synthase

Journal of Hypertension

Volumn 22, Issue 1, 2004, Pages 167-173

  Pecháňová, Olga ^a,b   Dobešová, Zdenka ^a   Čejka, Jakub ^a   Kuneš, Jaroslav ^a   Zicha, Josef ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Aminoguanidine; Blood pressure; Dimethylguanidine; N nitro L arginine methly ester; Nitric oxide synthase; Renin angiotensin system; Sympathetic nervous system

Indexed keywords

AMINOGUANIDINE; CAPTOPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PENTOLONIUM TARTRATE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME INDUCTION; EVALUATION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 18544407925     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200401000-00026     Document Type: Article

References (43)

1. Kuneš J, Dobešová Z, Zicha J. Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia. Clin Sci 2002; 102:269-277.
2. Zicha J, Dobešová Z, Kuneš J. Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anions. J Hypertens 2001; 19:247-254.
3. 2 hybrid studies. J Hypertens 2002; 20:945-955.
4. Arnal JF, el Amrani AI, Chatellier G, Menard J, Michel JB. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 1993; 22:380-387.
5. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90:278-281.
6. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992; 20:298-303.
7. G-nitro-L- arginine methyl ester. Hypertension 1996; 28:361-366.
8. Jover B, Herizi A, Casellas D, Mimran A. Influence of irbesartan and enalapril on changes of renal function associated with the established phase of L-NAME hypertension. J Hypertens 2001; 19:2039-2046.
9. Jover B, Herizi A, Ventre F, Dupont M, Mimran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 1993; 21:944-948.
10. Kalliovalkama J, Jolma P, Tolvanen JP, Kähönen M, Hutri-Kähönen N, Wu X, et al. Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism. Cardiovasc Res 1999; 42:773-782.
11. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 1993; 21:660-666.
12. Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, et al. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension 1997; 30:1621-1627.
13. Bernátová I, Pecháňová O, Šimko F. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Physiol Res 1996; 45:311-316.
14. Pecháňová O, Bernátová I, Pelouch V, Šimko F. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol 1997; 29:3365-3374.
15. G-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism. J Cardiovasc Pharmacol 2002; 40:478-486.
16. Cunha RS, Cabral AM, Vasquez EC. Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am J Hypertens 1993; 6:806-809.
17. 1- adrenergic tone in chronic nitric oxide blockade-induced hypertension. Am J Physiol 1994; 266:R1470-R1476.
18. Zanchi A, Schaad NC, Osterheld MC, Grouzmann E, Nussberger J, Brunner HR, Waeber B. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Am J Physiol 1995; 268:H2267-H2273.
19. Sander M, Hansen PG, Victor RG. Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension 1995; 26:691-695.
20. omega-nitro-L-arginine methyl ester. Hypertension 1997; 30:64-70.
21. Blanc J, Ponchon P, Laude D, Elghozi JL, Jover B. Blood pressure variability in established L-NAME hypertension in rats. J Hypertens 1999; 17:1527-1534.
22. Luvara G, Pueyo ME, Philippe M, Mandet C, Savoie F, Henrion D, Michel JB. Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism. Arterioscler Thromb Vasc Biol 1998; 18:1408-1416.
23. Qiu C, Baylis C. Dexamethasone worsens nitric oxide inhibition-induced hypertension and renal dysfunction. Am J Hypertens 2000; 13: 1097-1102.
24. Hasan K, Heesen BJ, Corbett JA, McDaniel ML, Chang K, Allison W, et al. Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 1993; 249:101-106.
25. Zhang W, Pettersson A, Thoren P, Hedner T. Effects of 1,1-dimethylguanidine administration on blood pressure, heart rate and renal sympathetic nerve activity in normotensive and spontaneously hypertensive rats. Acta Physiol Scand 1997; 159:1-6.
26. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 1999; 55:1015-1028.
27. Minami N, Imai Y, Hashimoto J, Abe K. Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats. Clin Sci 1995; 89:177-182.
28. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87:682-685.
29. Eshima K, Hirooka Y, Shigematsu H, Matsuo I, Koike G, Sakai K, Takeshita A. Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition. Hypertension 2000; 36:259-263.
30. 1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats. Med Sci Monit 2002; 8:BR378-BR384.
31. Navarro-Cid J, Maeso R, Rodrigo E, Munoz-Garcia R, Ruilope LM, Lahera V, Cachofeiro V. Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs. Am J Hypertens 1996; 9:1077-1083.
32. Akuzawa N, Nakamura T, Kurashina T, Saito Y, Hoshino J, Sakamoto H, et al. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis. Am J Hypertens 1998; 11:697-707.
33. Maeso R, Navarro-Cid J, Rodrigo E, Ruilope LM, Cachofeiro V, Lahera V. Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME. J Hypertens 1999; 17:221-227.
34. Küng CF, Moreau P, Takase H, Lüscher TF. L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil. Hypertension 1995; 26:744-751.
35. Fortepiani LA, Rodrigo E, Ortiz MC, Cachofeiro V, Atucha NM, Ruilope LM, et al. Pressure natriuresis in nitric oxide-deficient hypertensive rats: effect of antihypertensive treatments. J Am Soc Nephrol 1999; 10: 21-27.
36. Bergamaschi CT, Campos RR, Lopes OU. Rostral ventrolateral medulla: a source of sympathetic activation in rats subjected to long-term treatment with L-NAME. Hypertension 1999; 34:744-747.
37. Tsuchihashi T, Kagiyama S, Matsumura K, Lin Y, Abe I, Fujishima M. Cardiovascular responses to glutamate and angiotensin II in ventrolateral medulla of hypertension induced by chronic inhibition of nitric oxide. Hypertens Res 2000; 23:359-364.
38. Bergamaschi CT, Biancardi VC, Lopes OU, Campos RR. Effects of angiotensin blockade in the rostral ventrolateral medulla on maintenance of hypertension induced by chronic L-NAME treatment. Brain Res 2002; 927:195-199.
39. G-nitro-L-arginine methyl ester treatment in conscious rats. Hypertension 1994; 23:982-986.
40. Souza HCD, Ballejo G, Salgado MC, Da Silva VJ, Salgado HC. Cardiac sympathetic overactivity and decreased baroreflex sensitivity in L-NAME hypertensive rats. Am J Physiol 2001; 280:H844-H850.
41. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 1993; 22:812-818.
42. Rudd MA, Trolliet M, Hope S, Scribner AW, Daumerie G, Toolan G, et al. Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOS II inhibition. Am J Physiol 1999; 277:H732-H739.
43. Tan DY, Meng S, Cason GW, Manning RD. Mechanisms of salt-sensitive hypertension: role of inducible nitric oxide synthase. Am J Physiol 2000; 279:R2297-R2303.